Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition An early phase trial (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1097/md.0000000000020458
PubMed Identifier: 32590730
Publication URI: http://europepmc.org/abstract/MED/32590730
Type: Journal Article/Review
Parent Publication: Medicine
Issue: 26
ISSN: 0025-7974